Search Results - "ZHIFEI ZU"

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas by Wong, Kwong-Kwok, Tsang, Yvonne T.M, Deavers, Michael T, Mok, Samuel C, Zu, Zhifei, Sun, Charlotte, Malpica, Anais, Wolf, Judith K, Lu, Karen H, Gershenson, David M

“…Low-grade ovarian serous carcinomas are believed to arise via an adenoma-serous borderline tumor-serous carcinoma sequence. In this study, we found that…”
Get full text

The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated With Differentiation and Survival in Ovarian Cancer by KING, Erin R, TUNG, Celestine S, MOK, Samuel C, GERSHENSON, David M, WONG, Kwong-Kwok, TSANG, Yvonne T. M, ZHIFEI ZU, LOK, Gabriel T. M, DEAVERS, Michael T, MALPICA, Anais, WOLF, Judith K, LU, Karen H, BIRRER, Michael J

“…Low-grade (LG) serous ovarian carcinoma is believed to arise from serous borderline ovarian tumors; yet the progression from serous borderline tumors to LG…”
Get full text

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas by Crane, Erin K, Kwan, Suet-Yan, Izaguirre, Daisy I, Tsang, Yvonne T M, Mullany, Lisa K, Zu, Zhifei, Richards, JoAnne S, Gershenson, David M, Wong, Kwong-Kwok

“…Epithelial ovarian cancer is a diverse molecular and clinical disease, yet standard treatment is the same for all subtypes. TP53 mutations represent a node of…”
Get full text

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma by King, Erin R, Zu, Zhifei, Tsang, Yvonne T.M, Deavers, Michael T, Malpica, Anais, Mok, Samuel C, Gershenson, David M, Wong, Kwong-Kwok

“…Abstract Objective To validate the overexpression of insulin-like growth factor 1 (IGF-1) and its receptor (IGF-1R) in low-grade serous ovarian carcinoma…”
Get full text

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas by Tung, Celestine S, Mok, Samuel C, Tsang, Yvonne T M, Zu, Zhifei, Song, Huijuan, Liu, Jinsong, Deavers, Michael T, Malpica, Anais, Wolf, Judith K, Lu, Karen H, Gershenson, David M, Wong, Kwong-Kwok

“…Ovarian tumors of low malignant potential and low-grade ovarian serous carcinomas are thought to represent different stages on a tumorigenic continuum and to…”
Get full text

PAX2 Expression in Ovarian Cancer by Song, Huijuan, Kwan, Suet-Yan, Izaguirre, Daisy I, Zu, Zhifei, Tsang, Yvonne T, Tung, Celestine S, King, Erin R, Mok, Samuel C, Gershenson, David M, Wong, Kwong-Kwok

“…PAX2 is one of nine PAX genes that regulate tissue development and cellular differentiation in embryos. However, the functional role of PAX2 in ovarian cancer…”
Get full text

Cloning and Expression Analysis of a Novel Salicylate Suppressible Gene, Hs-CUL-3, a Member of Cullin/Cdc53 Family by Du, Min, Sansores-Garcia, Leticia, Zu, Zhifei, Wu, Kenneth Kun-yu

“…By using a mRNA differential display technique to search for salicylate suppressible genes, we identified a cDNA in human foreskin fibroblasts, which by…”
Get full text

Abstract 3474: GDF15 as a serum marker of cisplatin response in ovarian cancer cells by Izaguirre, Daisy I., Kwan, Suet Yan, Zu, Zhifei, Tsang-Lee, Yvonne T., Wong, Kwong-Kwok

“…Ovarian cancer treatment consists of surgery followed by a chemotherapy combination entailing a platinum agent (cisplatin/carboplatin) and a taxane…”
Get full text

Abstract 1708: Induction of GDF15 by cisplatin triggers apoptotic cell death in ovarian cancer cells by Izaguirre, Daisy I., Zu, Zhifei, Tsang-Lee, Yvonne T., Mok, Samuel, Wong, Kwong-Kwok

“…Ovarian cancer is the fifth most common cause of death among women. The overall five year survival is 45.6% as a result of late diagnosis when treatment is…”
Get full text

Abstract 5037: Sensitivity of ovarian clear cell carcinoma cells to PI3K inhibitors by Kwan, Suet Yan, Fung, Anita, Izaguirre, Daisy, Zu, Zhifei, Tsang-Lee, Yvonne, Mok, Samuel, Wong, Kwong-Kwok

“…Introduction: Ovarian Clear Cell Carcinoma (OCCC) is generally aggressive and chemoresistant, with five year survival rate of approximately 40%. Recent…”
Get full text

Abstract 5031: Insulin-like growth factor-1 (IGF-1) is upregulated in low-grade serous ovarian carcinoma by King, Erin R., Zu, Zhifei, Tsang-Lee, Yvonne T.M., Gershenson, David M., Mok, Samuel C., Wong, Kwong-Kwok

“…Introduction: Low-grade (LG) serous ovarian carcinomas are clinically and genetically distinct from high-grade serous ovarian carcinomas (HG), and emerging…”
Get full text

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas: e0135101 by Crane, Erin K, Kwan, Suet-Yan, Izaguirre, Daisy I, Tsang, Yvonne TM, Mullany, Lisa K, Zu, Zhifei, Richards, JoAnne S, Gershenson, David M, Wong, Kwong-Kwok

“…Epithelial ovarian cancer is a diverse molecular and clinical disease, yet standard treatment is the same for all subtypes. TP53 mutations represent a node of…”
Get full text

Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML by Deisseroth, A B, Zu, Z, Claxton, D, Hanania, E G, Fu, S, Ellerson, D, Goldberg, L, Thomas, M, Janicek, K, Anderson, W F

“…Relapse after autologous bone marrow transplantation for chronic myelogenous leukemia (CML) can be due either to the persistence of leukemia cells in systemic…”
Get full text

Genetic marking shows that Ph+ present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML by DEISSEROTH, A. B, ZHIFEI ZU, HESTER, J, KORBLING, M, DURETT, A, MOEN, R, BERENSON, R, HEIMFELD, S, HAMER, J, CALVERT, L, TIBBITS, P, TALPAZ, M, CLAXTON, D, KANTARJIAN, H, CHAMPLIN, R, READING, C, HANANIA, E. G, SIQING FU, ELLERSON, D, GOLDBERG, L, THOMAS, M, JANICEK, K, ANDERSON, W. F

Get full text